Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Vaxart, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 92 | 1 | 98 | +7 |
| Shares | 27.3M | 23.0K | 22.8M | −4.48M (−16.4%) |
| Value | $11.1M | $9.36K | $10.3M | −$799.8K (−7.2%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Vaxart, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 1,763,882 | $793.7K | 0.00% |
| Renaissance Technologies LLC | 597,443 | $270.0K | 0.00% |
| HRT Financial LP | 178,883 | $80.0K | 0.00% |
| Two Sigma Securities, LLC | 107,781 | $48.7K | 0.01% |
| Creative Planning | 73,225 | $33.1K | 0.00% |
| Gsa Capital Partners LLP | 48,548 | $22.0K | 0.00% |
| Oppenheimer & Co Inc | 37,950 | $17.2K | 0.00% |
| Manhattan West Asset Management, LLC | 30,256 | $13.7K | 0.00% |
| XTX Topco Ltd | 23,894 | $10.8K | 0.00% |
| Cascade Wealth Advisors, Inc | 25,035 | $9.51K | 0.01% |
| Qube Research & Technologies Ltd | 11,785 | $5.33K | 0.00% |
| SG Americas Securities, LLC | 10,575 | $5.00K | 0.00% |
| Engineers Gate Manager LP | 10,901 | $4.93K | 0.00% |
| Custos Family Office, LLC | 10,000 | $4.52K | 0.00% |
| FMR LLC | 200 | $90 | 0.00% |
| Ronald Blue Trust, Inc. | 160 | $72 | 0.00% |
| JNBA Financial Advisors | 5 | $3 | 0.00% |
Sold out (10)
Institutions that held Vaxart, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sio Capital Management, LLC | 5,583,448 | $2.27M |
| Silverarc Capital Management, LLC | 683,825 | $278.3K |
| Graham Capital Management, L.P. | 89,541 | $36.4K |
| Jane Street Group, LLC | 30,516 | $12.4K |
| Catalyst Funds Management Pty Ltd | 26,742 | $10.9K |
| Commonwealth Equity Services, LLC | 15,706 | $6.00K |
| Baader Bank INC | 13,633 | $4.39K |
| Cheviot Value Management, LLC | 85 | $35 |
| Synergy Investment Management, LLC | 30 | $12 |
| GWM Advisors LLC | 1 | $0 |
Not filed for Q2 2025 yet (1)
Institutions that held Vaxart, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| CAPROCK Group, Inc. | 23,000 | $9.36K |